Glenmark Pharmaceuticals inform about media release

11 Apr 2022 Evaluate

Glenmark Pharmaceuticals has attached a media release today titled ‘Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276 in patients with Advanced Solid Tumors and Hodgkin’s Lymphoma’. 

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1698.00 27.10 (1.62%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.